Regulon

Regulon: R-889

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
180.25680810Pr-171Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
3421 ENSG00000067829 IDH3G G5E9Q7
29888 ENSG00000090372 STRN4 Q9NRL3
5434 ENSG00000099817 POLR2E P19388
8220 ENSG00000100056 DGCR14 Q96DF8
85377 ENSG00000100139 MICALL1 Q8N3F8
4174 ENSG00000100297 MCM5 P33992
10295 ENSG00000103507 BCKDK O14874
54531 ENSG00000105556 MIER2 Q8N344
79080 ENSG00000110104 CCDC86 Q9H6F5
56926 ENSG00000125912 NCLN Q969V3
5605 ENSG00000126934 MAP2K2 P36507
11135 ENSG00000128283 CDC42EP1 Q00587
11047 ENSG00000130706 ADRM1 Q16186
5914 ENSG00000131759 RARA A8MUP8
3159 ENSG00000137309 HMGA1 P17096
726 ENSG00000149260 CAPN5 O15484
2783 ENSG00000172354 GNB2 Q6FHM2
10554 ENSG00000236873 AGPAT1 Q99943

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
MIRDAMETINIBMAP2K1Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 1 inhibitor20
TAZAROTENERARGSmall moleculeAGONISTRetinoic acid receptor agonist40
OPROZOMIBPSMD1Small moleculeINHIBITOR26S proteosome inhibitor10
NRX195183RARASmall moleculeAGONISTRetinoic acid receptor alpha agonist20
IXAZOMIBPSMD1Small moleculeINHIBITOR26S proteasome inhibitor40
BINIMETINIBMAP2K2Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 1 inhibitor40
COBIMETINIB FUMARATEMAP2K1Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 2 inhibitor40
RO-4987655MAP2K2Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 2 inhibitor10
COBIMETINIBMAP2K1Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 2 inhibitor40
WX-554MAP2K1Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 1 inhibitor10
AZD-8330MAP2K1Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 1 inhibitor10
TAMIBAROTENERARASmall moleculeAGONISTRetinoic acid receptor alpha agonist20
SELUMETINIB SULFATEMAP2K2Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase; MEK1/2 inhibitor43
PIMASERTIBMAP2K1Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 1 inhibitor20
ADAPALENERARGSmall moleculeAGONISTRetinoic acid receptor agonist40
ETRETINATERARGSmall moleculeAGONISTRetinoid receptor agonist40
ISOTRETINOINRARGSmall moleculeAGONISTRetinoic acid receptor agonist41
SELUMETINIBMAP2K1Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 2 inhibitor43
BORTEZOMIBPSMD1Small moleculeINHIBITOR26S proteosome inhibitor41
ACITRETINRARGSmall moleculeAGONISTRetinoid receptor agonist40
ALITRETINOINRARGSmall moleculeAGONISTRetinoid receptor agonist40
TRAMETINIBMAP2K2Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase; MEK1/2 inhibitor41
IXAZOMIB CITRATEPSMD1Small moleculeINHIBITOR26S proteosome inhibitor40
TRETINOINRARGSmall moleculeAGONISTRetinoic acid receptor agonist40
REFAMETINIBMAP2K2Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 2 inhibitor20
CI-1040MAP2K1Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 1 inhibitor20
TRAMETINIB DIMETHYL SULFOXIDEMAP2K2Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 2 inhibitor40
TAK-733MAP2K1Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 2 inhibitor10
CARFILZOMIBPSMD1ProteinINHIBITOR26S proteosome inhibitor40
AS-703988MAP2K1Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 2 inhibitor10

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-889

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs